Estimating cost-effectiveness in public health: a summary of modelling and valuation methods
about
Public health economics: a systematic review of guidance for the economic evaluation of public health interventions and discussion of key methodological issues.Clinical outcomes and neural correlates of 20 sessions of repetitive transcranial magnetic stimulation in severe and enduring anorexia nervosa (the TIARA study): study protocol for a randomised controlled feasibility trial.Choosing an epidemiological model structure for the economic evaluation of non-communicable disease public health interventions.Cost effectiveness of a multi-component school-based physical activity intervention targeting adolescents: the 'Physical Activity 4 Everyone' cluster randomized trialEconomic evaluation of vaccines: specificities and future challenges illustrated by recent European examples.Cost-effectiveness analysis in the Spanish setting of the PEAK trial of panitumumab plus mFOLFOX6 compared with bevacizumab plus mFOLFOX6 for first-line treatment of patients with wild-type RAS metastatic colorectal cancer.Comparing cost-effectiveness results for a vaccine across different countries worldwide: what can we learn?Investing in health: is social housing value for money? A cost-utility analysis.Economic evaluations of alcohol prevention interventions: Is the evidence sufficient? A review of methodological challenges.Improving accountability in vaccine decision-making.The cost-effectiveness of public health interventions examined by NICE from 2011 to 2016.2. How is the economic assessment of vaccines performed today?Towards a more comprehensive approach for a total economic assessment of vaccines?: 1. The building blocks for a health economic assessment of vaccination.
P2860
Q27006528-A3CA5084-2920-4CC1-AEDF-DA73B94B3D66Q36344084-9B4A9885-1D41-4718-80DB-F7A64BE93575Q36871294-595E9FCC-C0E1-409B-9755-674A4131B354Q37195900-75C35686-C410-4B51-806B-75BB52A66FDBQ38105340-2088BE74-00D3-4267-8F18-3B4C33200123Q39010073-C5918E48-56F4-45AE-B481-4E92820A6FACQ41694316-BEDABF19-4A7B-4B9E-8B52-8AAB495D1DF1Q44558112-6AD673A1-CBBB-42C8-96F9-875EF1F069B4Q47137452-F95308CC-79A8-45DF-AF7D-50299EE17C80Q48587929-ED9032DB-3136-423A-919D-C0E40FF404C3Q49607011-92196DBE-164F-4F40-92F6-FD2D7AE39EAAQ54989442-DED7E7F5-A716-4514-8FE5-F52F6C81AF55Q55031510-63667A41-D75F-4C96-AC49-C44410BB36FB
P2860
Estimating cost-effectiveness in public health: a summary of modelling and valuation methods
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Estimating cost-effectiveness ...... odelling and valuation methods
@ast
Estimating cost-effectiveness ...... odelling and valuation methods
@en
type
label
Estimating cost-effectiveness ...... odelling and valuation methods
@ast
Estimating cost-effectiveness ...... odelling and valuation methods
@en
prefLabel
Estimating cost-effectiveness ...... odelling and valuation methods
@ast
Estimating cost-effectiveness ...... odelling and valuation methods
@en
P2093
P2860
P356
P1476
Estimating cost-effectiveness ...... odelling and valuation methods
@en
P2093
Ceri J Phillips
Evelina Bertranou
Janine Hale
Kevin Marsh
Richard Fordham
P2860
P2888
P356
10.1186/2191-1991-2-17
P577
2012-09-03T00:00:00Z
P5875
P6179
1048248646